Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean P Polster

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Geroscience|June 20, 2020
Common transcriptome, plasma molecules, and imaging signatures in the aging brain and a Mendelian neurovascular disease, cerebral cavernous malformationJanne Koskimäki, Sean P Polster, Yan Li, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 20, 2025
Circulating molecules reflect imaging biomarkers of hemorrhage in cerebral cavernous malformationsStephanie F Hage, Dehua E Bi, Serena Kinkade, et al.
Journal of Magnetic Resonance Imaging : JMRI|September 14, 2019
Phantom validation of quantitative susceptibility and dynamic contrast-enhanced permeability MR sequences across instruments and sitesNicholas Hobson, Sean P Polster, Ying Cao, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 28, 2018
Phenotypic characterization of murine models of cerebral cavernous malformationsHussein A Zeineddine, Romuald Girard, Laleh Saadat, et al.
The Lancet. Neurology|March 22, 2025
Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trialIssam A Awad, Roberto J Alcazar-Felix, Agnieszka Stadnik, et al.
JCI Insight|June 21, 2019
Biomarkers of cavernous angioma with symptomatic hemorrhageSeán B Lyne, Romuald Girard, Janne Koskimäki, et al.
Neurosurgery|March 21, 2019
Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) ProcedureIssam A Awad, Sean P Polster, Julián Carrión-Penagos, et al.
Nature Communications|May 29, 2020
Permissive microbiome characterizes human subjects with a neurovascular disease cavernous angiomaSean P Polster, Anukriti Sharma, Ceylan Tanes, et al.
Neurosurgery|November 27, 2018
Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) TrialSean P Polster, Agnieszka Stadnik, Amy L Akers, et al.
Neurosurgery|January 21, 2021
Intracerebral Hemorrhage Volume Reduction and Timing of Intervention Versus Functional Benefit and Survival in the MISTIE III and STICH TrialsSean P Polster, Julián Carrión-Penagos, Seán B Lyne, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Geroscience|June 20, 2020
Common transcriptome, plasma molecules, and imaging signatures in the aging brain and a Mendelian neurovascular disease, cerebral cavernous malformationJanne Koskimäki, Sean P Polster, Yan Li, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 20, 2025
Circulating molecules reflect imaging biomarkers of hemorrhage in cerebral cavernous malformationsStephanie F Hage, Dehua E Bi, Serena Kinkade, et al.
Journal of Magnetic Resonance Imaging : JMRI|September 14, 2019
Phantom validation of quantitative susceptibility and dynamic contrast-enhanced permeability MR sequences across instruments and sitesNicholas Hobson, Sean P Polster, Ying Cao, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 28, 2018
Phenotypic characterization of murine models of cerebral cavernous malformationsHussein A Zeineddine, Romuald Girard, Laleh Saadat, et al.
The Lancet. Neurology|March 22, 2025
Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trialIssam A Awad, Roberto J Alcazar-Felix, Agnieszka Stadnik, et al.
JCI Insight|June 21, 2019
Biomarkers of cavernous angioma with symptomatic hemorrhageSeán B Lyne, Romuald Girard, Janne Koskimäki, et al.
Neurosurgery|March 21, 2019
Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) ProcedureIssam A Awad, Sean P Polster, Julián Carrión-Penagos, et al.
Nature Communications|May 29, 2020
Permissive microbiome characterizes human subjects with a neurovascular disease cavernous angiomaSean P Polster, Anukriti Sharma, Ceylan Tanes, et al.
Neurosurgery|November 27, 2018
Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) TrialSean P Polster, Agnieszka Stadnik, Amy L Akers, et al.
Neurosurgery|January 21, 2021
Intracerebral Hemorrhage Volume Reduction and Timing of Intervention Versus Functional Benefit and Survival in the MISTIE III and STICH TrialsSean P Polster, Julián Carrión-Penagos, Seán B Lyne, et al.
Pageof 7